Article
ELOVL2, a novel and potential tumor antigen guided mRNA vaccine development for retroperitoneal liposarcoma
2023-03-17
Abstract excerpt
<h4>Background: </h4> The exploration of lipid metabolism dysregulation may provide novel perspectives for retroperitoneal liposarcoma (RPLS). In our study, we aimed to investigate potential tumor antigen for mRNA vaccine development and facilitate further understanding of immune landscape in RPLS, through lipid metabolism-associated genes (LMAGs) based prognostic model. Methods Gene expression profiles and corre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- efa004f8-9d18-5bc3-aa6c-b1306d43815e
- DOI
- 10.21203/rs.3.rs-2688489/v1
